| COVID-19 and the environment: A critical review and research agenda MH Shakil, ZH Munim, M Tasnia, S Sarowar Science of the Total Environment 745, 141022, 2020 | 349 | 2020 |
| Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival MA Rahman, A Gras Navarro, J Brekke, A Engelsen, C Bindesbøll, ... British journal of cancer 121 (7), 545-555, 2019 | 38 | 2019 |
| Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma M Schneider, L Vollmer, AL Potthoff, VM Ravi, BO Evert, MA Rahman, ... Neuro-oncology 23 (11), 1885-1897, 2021 | 27 | 2021 |
| Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients M Bahador, A Gras Navarro, MA Rahman, M Dominguez-Valentin, ... Oncoimmunology 6 (8), e1336272, 2017 | 13 | 2017 |
| Structure‐Activity‐Relationship‐Aided Design and Synthesis of xCT Antiporter Inhibitors D Cirillo, S Sarowar, PØ Enger, HR Bjørsvik ChemMedChem 16 (17), 2650-2668, 2021 | 7 | 2021 |
| Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway MA Rahman, AST Engelsen, S Sarowar, C Bindesbøll, E Birkeland, ... Frontiers in Cell and Developmental Biology 10, 1022191, 2022 | 6 | 2022 |
| The styryl benzoic acid derivative DC10 potentiates radiotherapy by targeting the xCT-glutathione Axis S Sarowar, D Cirillo, P Játiva, MH Nilsen, SMA Otragane, J Heggdal, ... Frontiers in Oncology 12, 786739, 2022 | 2 | 2022 |
| Bortezomib sensitizes glioblastoma with unmethylated MGMT promoter to temozolomide-chemotherapy through MGMT depletion and abrogated autophagy flux MA Rahman, AG Navarro, J Brekke, C Bindesbøll, A Engelsen, S Sarowar, ... Cancer Research 78 (13_Supplement), 2928-2928, 2018 | 2 | 2018 |
| Therapy HR Bjørsvik, PØ Enger, D Cirillo, S Sarowar US Patent App. 17/763,367, 2022 | | 2022 |
| CTNI-40. PHASE I TRIAL OF SULFASALAZINE COMBINED WITH STEREOTACTIC RADIOSURGERY FOR RECURRENT GLIOBLASTOMA: STUDY PROTOCOL FOR NCT04205357 BS Skeie, S Bragstad, S Sarowar, M Behbahani, C Filippi, J Knisely, ... Neuro-Oncology 24 (Suppl 7), vii80, 2022 | | 2022 |
| Styrylbenzoic acid derivative DC10 potentiates radiotherapy by inhibiting glutathione synthesis, leading to increased oxidative stress and cancer cell death S Sarowar, D Cirillo, P Jativa, MH Nilsen, SMA Otragane, JI Heggdal, ... Cancer Research 82 (12_Supplement), 214-214, 2022 | | 2022 |
| A novel 13-basepair deletion in CSPG4/NG2 abrogates protein expression, glioblastoma proliferation and invasion in vitro and in vivo in mice VS Arnesen, S Suntharalingam, Ż Matuszek, S Sarowar, S Knappskog, ... Cancer Research 82 (12_Supplement), 3996-3996, 2022 | | 2022 |
| Front Cover: Structure‐Activity‐Relationship‐Aided Design and Synthesis of xCT Antiporter Inhibitors (ChemMedChem 17/2021) D Cirillo, S Sarowar, P Øyvind Enger, HR Bjørsvik ChemMedChem 16 (17), 2546-2546, 2021 | | 2021 |
| Treatment with Bortezomib Sensitizes Glioblastoma Cells to Temozolomide S Sarowar The University of Bergen, 2016 | | 2016 |
